Drugs / Lu-177-ITG-PSMA-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05420727 | Feb 2023 → Apr 2024 | soft tissue sarcoma | John O. Prior | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu-177-ITG-PSMA-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05420727 ↗ |